
Read NVIC's Essential College Guide to learn about college vaccine requirements before enrollment.

Learn about vaccine requirements, exemptions, and federal privacy protections in K-12 and daycare settings.

The FDA's Vaccines and Related Biological Products Advisory Committee voted to recommend updating the COVID-19 vaccine to include a SARS-CoV-2 JN.1 lineage strain, citing the current vaccine's ineffectiveness against emerging variants. Despite the absence of safety data, the committee emphasized the importance of vaccine effectiveness, while noting the potential for rapid variant evolution which might impact vaccine efficacy. Manufacturers like Moderna, Pfizer, and Novavax presented promising data for their new vaccine candidates, with an emphasis on preparedness to meet the FDA's upcoming strain decision.
.png)
Learn about the ACIP recommendation for Pfizer's Abrysvo RSV vaccine in pregnant women, the controversy surrounding its testing, and the potential impact on preterm births – all in our eye-opening article on RSV vaccination strategies.

Learn about federal law and parent consent rights for vaccination in school-based health centers.

Learn about federal student privacy laws and being proactive to keep vaccination information private.

Learn about school vaccine requirements, exemptions and national policy being developed to teach children about vaccines in the classroom.

Learn about CDC's treatment of the RSV drug nirsevimab as a vaccine and potential impacts to vaccine mandates, tracking and injury compensation.

Read NVIC's referenced public comment on FDA future COVID-19 regimens and call for withdrawal of mRNA COVID-19 vaccines.
NVIC’s 2023 Annual Report on U.S. State Vaccine Legislation
Read about the record-breaking number of good vaccine-related bills that passed during the 2023 state legislative session.